10-15 ASSOCIATES, INC. - GW PHARMACEUTICALS PLC ownership

Quarter-by-quarter ownership
10-15 ASSOCIATES, INC. ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q2 2020$205,000
-28.8%
1,6700.0%0.04%
-33.9%
Q2 2019$288,000
+4.3%
1,670
+1.8%
0.06%
+5.1%
Q1 2019$276,000
+10.8%
1,640
+13.9%
0.06%
+5.4%
Q3 2018$249,000
+9.2%
1,440
-11.9%
0.06%
+9.8%
Q2 2018$228,0001,6350.05%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q3 2023
NameSharesValueWeighting ↓
Chicago Capital Management, LLC 86,069$18,668,0008.69%
BARDIN HILL MANAGEMENT PARTNERS LP 170,108$36,897,0006.84%
HARVEST MANAGEMENT LLC 44,100$9,565,0005.72%
Twin Securities, Inc. 39,541$8,576,0005.50%
TIG Advisors, LLC 572,743$124,228,0004.67%
ALPINE ASSOCIATES MANAGEMENT INC. 787,500$170,810,0004.63%
First Trust Capital Management L.P. 105,822$22,953,0004.49%
Pentwater Capital Management LP 2,102,104$455,946,0004.35%
OMNI PARTNERS LLP 403,061$87,424,0004.31%
SPRING CREEK CAPITAL LLC 370,000$80,253,0003.47%
View complete list of GW PHARMACEUTICALS PLC shareholders